Tectonic Therapeutic | AVRO - Ebitda



Tectonic Therapeutic reported $-13483000 in EBITDA for its fiscal quarter ending in December of 2024.


Ebitda Change Date
Alnylam Pharmaceuticals USD 18.83M 13.65M Jun/2025
Celltrion KRW 221.03B 57.43B Mar/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -34828000 2.99M Jun/2025
Divis Laboratories Ltd 7.29B 2.43B Jun/2025
Gilead Sciences USD 3.4B 797M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Kangmei Pharma -3262057.35 15.91M Sep/2024
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
MacroGenics USD -33437000 17.35M Jun/2025
Malin Corporation EUR -1100000 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Organigram Holdings CAD 2.68M 18.86M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Pharma Mar EUR 26.15M 27.2M Jun/2025
Qiagen NV USD 208.98M 38.23M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Sartorius EUR 264.3M 1.3M Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Takeda JPY 366.2B 238.06B Jun/2025
Tilray USD -101000 2.32M Nov/2024
Zhangzhou Pientzehuang Pharmaceutical 1.19B 829.65M Mar/2025